Planned Post‐Chemoradiation Neck Dissection: Significance of Radiation Dose
- 2 January 2006
- journal article
- research article
- Published by Wiley in The Laryngoscope
- Vol. 116 (1) , 33-36
- https://doi.org/10.1097/01.mlg.0000185846.27617.fe
Abstract
Objective: The increasing prominence of multimodality therapy for patients with advanced head and neck cancer reflects its high survival and functional preservation rates. We report the pathologic data on patients undergoing neck dissection (ND) after induction chemotherapy followed by concomitant chemoradiotherapy (IC‐CRT) in three similar protocols utilizing decreasing doses of radiation therapy.Materials and Methods: The databases of 221 patients who underwent IC‐CRT between 1999 and 2002 were reviewed. Based on posttreatment residual or pretreatment N2a or greater neck disease, 73 patients without pretreatment neck surgery were eligible for analysis (1 N1, 3 N2a, 26 N2b, 20 N2c, 23 N3). Three additional subgroups were also analyzed with respect to outcome: Undissected patients with less than N2 disease, patients who had neck surgery prior to IC‐CRT, and patients with N2a or greater neck disease who did not have post‐IC‐CRT ND.Study Design: Retrospective analysis.Results: Sixty‐seven patients underwent unilateral or bilateral selective neck dissection. Six patients had modified or radical ND. There were no wound healing complications. Pathologic analysis revealed viable cancer in 15 of 73 patients (20.5%): 1 had N1, 3 had N2b, 4 had N2c, and 7 had N3 neck disease. The incidence of viable cancer in the neck dissection specimen increased as radiation dose decreased. Complete response induction chemotherapy predicted negative pathology (P = .003). In the subgroup analysis, patients who had pretreatment surgery had a lower risk of dying from the primary cancerConclusions: 1) The incidence of positive pathology after IC‐CRT increases as radiation dose decreases. 2) Selective neck dissection after CRT has been demonstrated to be feasible and safe; the complication rate of ND after IC‐CRT is acceptably low. 3) There is viable posttreatment cancer in 20.5% of patients, indicating necessity of ND in these patients.Keywords
This publication has 10 references indexed in Scilit:
- Planned Neck Dissection after Concomitant Radiochemotherapy for Advanced Head and Neck CancerThe Laryngoscope, 2005
- Effectiveness of Chemotherapy and Radiotherapy in Sterilizing Cervical Nodal Disease in Squamous Cell Carcinoma of the Head and NeckThe Laryngoscope, 2005
- Is there a role for selective neck dissection after chemoradiation for head and neck cancer?Journal of the American College of Surgeons, 2004
- Neck dissection in the combined‐modality therapy of patients with locoregionally advanced head and neck cancerHead & Neck, 2004
- The Role of Computed Tomographic Scans in the Management of the N-Positive Neck in Head and Neck Squamous Cell Carcinoma After ChemoradiotherapyJAMA Otolaryngology–Head & Neck Surgery, 2004
- Who merits a neck dissection after definitive chemoradiotherapy for N2–N3 squamous cell head and neck cancer?Head & Neck, 2003
- Weekly Carboplatin and Paclitaxel Followed by Concomitant Paclitaxel, Fluorouracil, and Hydroxyurea Chemoradiotherapy: Curative and Organ-Preserving Therapy for Advanced Head and Neck CancerJournal of Clinical Oncology, 2003
- Induction Chemotherapy Followed by Concomitant Chemoradiation‐Induced Regression of Advanced Cervical Lymphadenopathy in Head and Neck Cancer as a Predictor of OutcomeOtolaryngology -- Head and Neck Surgery, 2002
- The Role of Cervical Lymphadenectomy After Aggressive Concomitant ChemoradiotherapyJAMA Otolaryngology–Head & Neck Surgery, 2000
- Management Implications of Evaluating the N2 and N3 Neck After Organ Preservation TherapyThe Laryngoscope, 1999